Fulcrum Therapeutics Stock Momentum Indicators Directional Movement Index

FULC Stock  USD 3.85  0.10  2.53%   
Fulcrum Therapeutics momentum indicators tool provides the execution environment for running the Directional Movement Index indicator and other technical functions against Fulcrum Therapeutics. Fulcrum Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Directional Movement Index indicator function is designed to identify and follow existing trends. Momentum indicators of Fulcrum Therapeutics are pattern recognition functions that provide distinct formation on Fulcrum Therapeutics potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

The output start index for this execution was ten with a total number of output elements of fifty-one. The Directional Movement Index is an indicator that is used in technical analysis to determine if Fulcrum Therapeutics is trending in particular direction.

Fulcrum Therapeutics Technical Analysis Modules

Most technical analysis of Fulcrum Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Fulcrum from various momentum indicators to cycle indicators. When you analyze Fulcrum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Fulcrum Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fulcrum Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Fulcrum Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Fulcrum Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Fulcrum Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Fulcrum Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Fulcrum Therapeutics, we also check how macroeconomic factors affect Fulcrum Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding78.2862.21292.65307.28
PTB Ratio2.961.651.761.67
Hype
Prediction
LowEstimatedHigh
0.203.9612.90
Details
Intrinsic
Valuation
LowRealHigh
0.275.3514.29
Details
Naive
Forecast
LowNextHigh
0.073.4012.34
Details
8 Analysts
Consensus
LowTargetHigh
9.2910.2111.33
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Business Services Idea
Business Services
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 40 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
When determining whether Fulcrum Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fulcrum Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fulcrum Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fulcrum Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulcrum Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Fulcrum Stock refer to our How to Trade Fulcrum Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulcrum Therapeutics. If investors know Fulcrum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulcrum Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.29)
Revenue Per Share
1.317
Quarterly Revenue Growth
89.909
Return On Assets
(0.07)
Return On Equity
(0.07)
The market value of Fulcrum Therapeutics is measured differently than its book value, which is the value of Fulcrum that is recorded on the company's balance sheet. Investors also form their own opinion of Fulcrum Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fulcrum Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulcrum Therapeutics' market value can be influenced by many factors that don't directly affect Fulcrum Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulcrum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulcrum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulcrum Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.